These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 9446006

  • 1. [Effect of diltiazem on concentration of cyclosporin metabolites in Sandimmune and Neoral treated kidney transplant patients].
    Sperschneider H, Wagner C, Korn A, Christians U.
    Med Klin (Munich); 1997 Oct 15; 92(10):589-96. PubMed ID: 9446006
    [Abstract] [Full Text] [Related]

  • 2. Randomized trial of cyclosporine microemulsion (neoral) versus conventional cyclosporine in liver transplantation: MILTON study. Multicentre International Study in Liver Transplantation of Neoral.
    Otto MG, Mayer AD, Clavien PA, Cavallari A, Gunawardena KA, Mueller EA.
    Transplantation; 1998 Dec 27; 66(12):1632-40. PubMed ID: 9884251
    [Abstract] [Full Text] [Related]

  • 3. Cyclosporine microemulsion increases drug exposure and reduces acute rejection without incremental toxicity in de novo renal transplantation. International Sandimmun Neoral Study Group.
    Keown P, Niese D.
    Kidney Int; 1998 Sep 27; 54(3):938-44. PubMed ID: 9734620
    [Abstract] [Full Text] [Related]

  • 4. Safety and tolerability of a new oral formulation of cyclosporin A, Sandimmun Neoral, in renal transplant patients.
    Taesch S, Niese D.
    Transpl Int; 1994 Sep 27; 7 Suppl 1():S263-6. PubMed ID: 11271220
    [Abstract] [Full Text] [Related]

  • 5. Pharmacokinetics of cyclosporine in heart transplant recipients receiving metabolic inhibitors.
    Akhlaghi F, Keogh AM, McLachlan AJ, Kaan A.
    J Heart Lung Transplant; 2001 Apr 27; 20(4):431-8. PubMed ID: 11295581
    [Abstract] [Full Text] [Related]

  • 6. Randomized, double-blind, one-year study of the safety and tolerability of cyclosporine microemulsion compared with conventional cyclosporine in renal transplant patients. International Sandimmun Neoral Study Group.
    Frei UA, Neumayer HH, Buchholz B, Niese D, Mueller EA.
    Transplantation; 1998 Jun 15; 65(11):1455-60. PubMed ID: 9645802
    [Abstract] [Full Text] [Related]

  • 7. Consistent absorption of cyclosporine from a microemulsion formulation assessed in stable renal transplant recipients over a one-year study period.
    Wahlberg J, Wilczek HE, Fauchald P, Nordal KP, Heaf JG, Olgaard K, Hansen JM, Lokkegaard H, Mueller EA, Kovarik JM.
    Transplantation; 1995 Oct 15; 60(7):648-52. PubMed ID: 7570970
    [Abstract] [Full Text] [Related]

  • 8. Pharmacokinetic, hemodynamic, and metabolic effects of cyclosporine sandimmune versus the microemulsion neoral in heart transplant recipients.
    White M, Pelletier GB, Tan A, Jesina C, Carrier M.
    J Heart Lung Transplant; 1997 Aug 15; 16(8):787-94. PubMed ID: 9286770
    [Abstract] [Full Text] [Related]

  • 9. Randomized, trough blood cyclosporine concentration-controlled trial to compare the pharmacodynamics of Sandimmune and Neoral in de novo lung transplant recipients.
    Trull A, Steel L, Sharples L, Stewart S, Parameshwar J, McNeil K, Wallwork J.
    Ther Drug Monit; 1999 Feb 15; 21(1):17-26. PubMed ID: 10051050
    [Abstract] [Full Text] [Related]

  • 10. Effects of combined oral treatments with cyclosporine A and nifedipine or diltiazem on drug-induced gingival overgrowth in rats.
    Morisaki I, Fukui N, Fujimori Y, Murakami J, Daikoku H, Amano A.
    J Periodontol; 2000 Mar 15; 71(3):438-43. PubMed ID: 10776932
    [Abstract] [Full Text] [Related]

  • 11. Effect of grapefruit juice on Sandimmun Neoral absorption among stable renal allograft recipients.
    Bistrup C, Nielsen FT, Jeppesen UE, Dieperink H.
    Nephrol Dial Transplant; 2001 Feb 15; 16(2):373-7. PubMed ID: 11158415
    [Abstract] [Full Text] [Related]

  • 12. A randomized, double-blind study comparing the efficacy, safety and optimal dose of two formulations of cyclosporin, Neoral and Sandimmun, in patients with severe psoriasis. OLP302 Study Group.
    Koo J.
    Br J Dermatol; 1998 Jul 15; 139(1):88-95. PubMed ID: 9764154
    [Abstract] [Full Text] [Related]

  • 13. How to convert from traditional cyclosporine to the microemulsion formulation in stable renal transplant patients?
    Gaspari F, Perico N, Pisoni R, Anedda MF, Signorini O, Caruso R, Gotti E, Remuzzi G.
    Clin Transplant; 1998 Oct 15; 12(5):379-90. PubMed ID: 9787945
    [Abstract] [Full Text] [Related]

  • 14. [A comparative randomized prospective multicenter study of Sandimmune vs Neoral in liver transplantation].
    Roy A, Grant DR, Kneteman NM, Tchervenkov JI, Levy GA, Tan A, Hendricks L.
    Ann Chir; 1998 Oct 15; 52(8):716-21. PubMed ID: 9846420
    [Abstract] [Full Text] [Related]

  • 15. Pharmacokinetics of oral cyclosporine (Neoral) in heart transplant recipients during the immediate period after surgery.
    Banner NR, David OJ, Leaver N, Davis J, Breen J, Johnston A, Yacoub MH.
    Transpl Int; 2002 Dec 15; 15(12):649-54. PubMed ID: 12478413
    [Abstract] [Full Text] [Related]

  • 16. Long-term follow-up of co-administration of diltiazem and cyclosporine in Chinese kidney transplant recipients.
    Xue W, Ding X, Tian P, Pan X, Yan H, Hou J, Feng X, Xiang H, Tian X.
    Ren Fail; 2010 Jan 15; 32(3):314-9. PubMed ID: 20370446
    [Abstract] [Full Text] [Related]

  • 17. A study to assess the efficacy, tolerability, and safety of a new oral formulation of Sandimmun--Sandimmun Neoral--in stable renal transplant patients.
    Rosental R, Bicans J, Berzina R, Zezina L.
    Transplant Proc; 1995 Dec 15; 27(6):3436-7. PubMed ID: 8540038
    [No Abstract] [Full Text] [Related]

  • 18. Neoral induction in pediatric renal transplantation.
    Bunchman TE, Parekh RS, Flynn JT, Smoyer WE, Kershaw DB, Valentini RP, Pontillo BJ, Sandvordenker J, Brown C, Sedman AB.
    Pediatr Nephrol; 1998 Jan 15; 12(1):2-5. PubMed ID: 9502556
    [Abstract] [Full Text] [Related]

  • 19. Safety of Neoral conversion in maintenance renal transplant patients: A one-year, double-blind study. NOVARTIS OLN-353 Study Group.
    Brennan DC, Barbeito R, Burke J, Brayman K, Greenstein S, Chang T.
    Kidney Int; 1999 Aug 15; 56(2):685-91. PubMed ID: 10432409
    [Abstract] [Full Text] [Related]

  • 20. Risk factors of cyclosporine nephrotoxicity after conversion from Sandimmune to Neoral.
    Sijpkens YW, Mallat MJ, Siegert CE, Zwinderman AH, Westendorp RG, de Fijter JW, van Es LA, Paul LC.
    Clin Nephrol; 2001 Feb 15; 55(2):149-55. PubMed ID: 11269679
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.